Vaxart, Inc.: Form 10-Q for the period ended Dec 31, 2015
Filed with the SEC on Feb 8, 2016 and accepted by EDGAR at Feb 8, 2016, 16:57 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-10-01 to 2015-12-31 | $1.7m | us-gaap:Revenues |
| Revenue | 6 months2015-07-01 to 2015-12-31 | $3.4m | us-gaap:Revenues |
| Research and development | 3 months2015-10-01 to 2015-12-31 | $6.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2015-07-01 to 2015-12-31 | $11.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2015-10-01 to 2015-12-31 | −$6.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2015-07-01 to 2015-12-31 | −$13.3m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2015-10-01 to 2015-12-31 | −$6.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months2015-07-01 to 2015-12-31 | −$13.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-10-01 to 2015-12-31 | −$0.17 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2015-07-01 to 2015-12-31 | −$0.34 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-10-01 to 2015-12-31 | −$0.17 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2015-07-01 to 2015-12-31 | −$0.34 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-10-01 to 2015-12-31 | 38,636,946 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2015-07-01 to 2015-12-31 | 38,630,587 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2015-07-01 to 2015-12-31 | −$8.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2015-12-31 | $39.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-12-31 | $58.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-12-31 | $64.2m | us-gaap:Assets |
| Current liabilities | At period end2015-12-31 | $6.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-12-31 | $6.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2015-12-31 | $57.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-16-024933. Last ingested by Listed: Nov 5, 2026, 18:48 ET. Listed shows no prices and gives no investment advice.